Upstream Bio (UPB) Current Leases (2023 - 2026)

Upstream Bio's Current Leases history runs 4 years deep, the most recent figure standing at $724000.0 for Q1 2026.

• In Q1 2026, Current Leases rose 2.26% year-over-year to $724000.0; the TTM figure through Mar 2026 stood at $724000.0 (up 2.26% YoY), while the FY2025 annual figure was $720000.0, up 2.27% from the prior year.
• Current Leases for Q1 2026 stood at $724000.0, up from $720000.0 in the prior quarter.
• The five-year high for Current Leases was $724000.0 in Q1 2026, with the low at $45000.0 in Q4 2023.
• The 4-year median for Current Leases is $710000.0 (2025), against an average of $625875.0.
• The sharpest annual moves came in 2024 and 2026: Current Leases soared 1464.44% in 2024, then grew 2.26% in 2026.
• Upstream Bio's Current Leases stood at $45000.0 in 2023, then jumped by 1464.44% to $704000.0 in 2024, then climbed by 2.27% to $720000.0 in 2025, then grew by 0.56% to $724000.0 in 2026.
• Business Quant data shows UPB's Current Leases at $724000.0 in Q1 2026, $720000.0 in Q4 2025, and $716000.0 in Q3 2025.